Dr Reddy’s was among the first to race off the blocks with four launches in India about as many years. But things have slowed since.

Infimab has been introduced in the Indian market through a licensing partnership with Epirus Biopharmaceuticals, Ranbaxy said in a statemen...

Ranbaxy Laboratories have entered into a licensing pact with EPIRUS Switzerland GmbH for treating rheumatoid arthiritis.